Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.4300
+0.0035 (0.82%)
At close: Jul 30, 2026, 4:00 PM EDT
0.4300
0.00 (0.00%)
After-hours: Jul 30, 2026, 4:10 PM EDT
Impact BioMedical Market Cap
Impact BioMedical has a market cap or net worth of $46.36 million as of July 30, 2026. Its market cap has increased by 490.93% in one year.
Market Cap
46.36M
Enterprise Value
47.45M
1-Year Change
490.93%
Ranking
Category
Stock Price
$0.43
ChartMarket Cap Chart
Since the IPO on September 16, 2024, Impact BioMedical's market cap has increased from $34.49M to $46.36M, an increase of 34.41%. That is a compound annual growth rate of 17.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 46.36M | -12.25% |
| Dec 31, 2025 | 52.83M | 216.73% |
| Dec 31, 2024 | 16.68M | -51.64% |
| Sep 16, 2024 | 34.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immutep | 49.47M |
| Eloxx Pharmaceuticals | 48.88M |
| Instil Bio | 48.49M |
| Mereo BioPharma Group | 48.22M |
| BeyondSpring | 48.11M |
| aTyr Pharma | 48.01M |
| Edesa Biotech | 47.57M |
| Seres Therapeutics | 46.97M |